Geistlich Pharma North America

Geistlich Pharma North America

Medical Devices, 400 Alexander Park, Princeton, New Jersey, 08540, United States, 51-200 Employees

geistlich-na.com

  • facebook
  • LinkedIn

phone no Phone Number: +14*********

Who is GEISTLICH PHARMA NORTH AMERICA

Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root,...

Read More

map
  • 400 Alexander Park, Princeton, New Jersey, 08540, United States Headquarters: 400 Alexander Park, Princeton, New Jersey, 08540, United States
  • 2012 Date Founded: 2012
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 5047 | NAICS Code: 423450 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GEISTLICH PHARMA NORTH AMERICA

Geistlich Pharma North America Org Chart and Mapping

Employees

Hannah Biss

Territory Sales Manager

John Halkiadakis

Senior Manager, Clinical Research & Upstream Marketing

Pam Hornickle

Quality, Regulatory and Compliance Manager - Leadership Team

Kathryn Garza

Senior Territory Manager

Cindy Penn

Regenerative Specialist

Steven Diorio

Digital Marketing Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Geistlich Pharma North America

Answer: Geistlich Pharma North America's headquarters are located at 400 Alexander Park, Princeton, New Jersey, 08540, United States

Answer: Geistlich Pharma North America's phone number is +14*********

Answer: Geistlich Pharma North America's official website is https://geistlich-na.com

Answer: Geistlich Pharma North America's revenue is $10 Million to $25 Million

Answer: Geistlich Pharma North America's SIC: 5047

Answer: Geistlich Pharma North America's NAICS: 423450

Answer: Geistlich Pharma North America has 51-200 employees

Answer: Geistlich Pharma North America is in Medical Devices

Answer: Geistlich Pharma North America contact info: Phone number: +14********* Website: https://geistlich-na.com

Answer: Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root, Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide and is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. Geistlich continues to lead oral regeneration based upon our history of quality, scientific collaboration, and manufacturing excellence. Every Geistlich biomaterial is intentionally designed for a specific application and carefully engineered to preserve its natural structures. Today, our full product portfolio of Bone Substitutes, Membranes, and Matrices increases clinical flexibility and expands treatment options in a variety of therapeutic areas. Geistlich Bio-Oss: Derived from bovine bone and preserved through a unique, patented process, making it highly similar to human bone. Geistlich Bio-Oss remains the essential choice among an expanding range of therapeutic areas through its unique properties and reliable clinical outcomes. Geistlich Bio-Gide: A unique bilayer collagen membrane designed to ensure optimal regenerative healing of bone and soft tissue. It provides excellent wound stability and graft containment with optimal protection for bone regeneration. Geistlich Mucograft: A collagen matrix designed for gain of keratinized tissue and recession coverage where open healing is required. Geistlich Fibro-Gide: The first volume-stable collagen matrix designed for soft-tissue augmentation around natural teeth and implants as a submerged scaffold where an increase in soft-tissue thickness is clinically desired.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access